Article Details

Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile ...

Retrieved on: 2024-06-12 05:34:50

Tags for this article:

Click the tags to see associated articles and topics

Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile .... View article details on hiswai:

Excerpt

... response to corticosteroids or who ... immune system to produce optimized fully human antibodies. ... Regeneron (NASDAQ: REGN) is a leading biotechnology ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up